1. Home
  2. SEPN vs FBYD Comparison

SEPN vs FBYD Comparison

Compare SEPN & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • FBYD
  • Stock Information
  • Founded
  • SEPN 2022
  • FBYD 2021
  • Country
  • SEPN United States
  • FBYD United States
  • Employees
  • SEPN N/A
  • FBYD N/A
  • Industry
  • SEPN
  • FBYD
  • Sector
  • SEPN
  • FBYD
  • Exchange
  • SEPN NYSE
  • FBYD Nasdaq
  • Market Cap
  • SEPN 311.6M
  • FBYD 300.5M
  • IPO Year
  • SEPN 2024
  • FBYD N/A
  • Fundamental
  • Price
  • SEPN $9.25
  • FBYD $7.00
  • Analyst Decision
  • SEPN Buy
  • FBYD
  • Analyst Count
  • SEPN 4
  • FBYD 0
  • Target Price
  • SEPN $27.00
  • FBYD N/A
  • AVG Volume (30 Days)
  • SEPN 2.6M
  • FBYD 15.5K
  • Earning Date
  • SEPN 05-15-2025
  • FBYD 05-15-2025
  • Dividend Yield
  • SEPN N/A
  • FBYD N/A
  • EPS Growth
  • SEPN N/A
  • FBYD N/A
  • EPS
  • SEPN N/A
  • FBYD N/A
  • Revenue
  • SEPN $977,000.00
  • FBYD $6,937,000.00
  • Revenue This Year
  • SEPN N/A
  • FBYD N/A
  • Revenue Next Year
  • SEPN N/A
  • FBYD N/A
  • P/E Ratio
  • SEPN N/A
  • FBYD $445.63
  • Revenue Growth
  • SEPN 108.76
  • FBYD N/A
  • 52 Week Low
  • SEPN $4.17
  • FBYD $3.62
  • 52 Week High
  • SEPN $28.99
  • FBYD $13.25
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • FBYD 48.44
  • Support Level
  • SEPN N/A
  • FBYD $6.28
  • Resistance Level
  • SEPN N/A
  • FBYD $7.30
  • Average True Range (ATR)
  • SEPN 0.00
  • FBYD 0.57
  • MACD
  • SEPN 0.00
  • FBYD -0.03
  • Stochastic Oscillator
  • SEPN 0.00
  • FBYD 28.69

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About FBYD Falcon's Beyond Global Inc.

Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.

Share on Social Networks: